Detection and Treatment of Alzheimer's Disease
The A4 Study, a groundbreaking international clinical trial was featured on CBS News. The study is the first to examine early treatment of older adults at risk for Alzheimer's disease with the hope of preventing memory loss before it begins. Learn more about the A4 study and other studies for Alzheimer's disease.
Dana-Farber/Brigham and Women's Cancer Center announces a new quick access program that provides for appointments with an oncologist as soon as the next day for newly-diagnosed adult patients. Request an appointment.
Ranked #5 for cardiac care by US News & World Report, BWH's Heart & Vascular Center reports on the state of innovations here, current clinical trials, quality and patient satisfaction, research funding, and BWH's leadership in the field of heart and vascular care.
Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests, creating a precise "tumor profile" of genetic changes for each patient's cancer that aid in selecting specific therapeutic agents to precisely treat each individual's cancer.
- Evolocumab, a PCSK9 inhibitor, Reduces Cardiovascular Events Research suggests that evolocumab may reduce the number of cardiovascular events.
- Longer Duration Anti-Platelet Therapy is Beneficial for Patients with History of Heart Attack New research finds that ticagrelor use beyond one year reduces risk.